Terminal restlessness and sedation: A note of caution [4]

Palliative Medicine

Volumn 17, Issue 5, 2003, Pages 469-

  Heyse Moore, Louis ^a  

^a St Joseph's Hospice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LEVOMEPROMAZINE; RISPERIDONE; SCOPOLAMINE; SEDATIVE AGENT; TRANQUILIZER;

CONSCIOUSNESS; DYING; HEALTH CARE PERSONNEL; HUMAN; LETTER; MEDICAL ETHICS; RESTLESSNESS; SEDATION; SLEEP DEPRIVATION; TERMINAL CARE; TERMINAL DISEASE;

CONSCIOUS SEDATION; HUMANS; PSYCHOMOTOR AGITATION; TERMINAL CARE; TERMINOLOGY;

EID: 0038690071     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216303pm783xx     Document Type: Letter

References (3)

1. Twycross R. Symptom management in advanced cancer, second edition. Oxford: Radcliffe Medical Press, 1997: 114.
2. Twycross R, Lichter I. The terminal phase. In: Doyle D, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine, second edition. Oxford: Oxford University Press, 1998: 987-88.
3. Heyse-Moore LH, Johnson-Bell, VE. Can doctors accurately predict the life expectancy of patients with terminal cancer? Palliat Med 1987; 1: 165-66.